These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3276494)

  • 61. Pleural involvement of dialysis-related amyloidosis.
    Suzuki M; Betsuyaku T; Kojima T; Saito H; Nishiura Y; Fukasawa Y; Nishimura M; Kawakami Y
    Intern Med; 2005 Jun; 44(6):628-31. PubMed ID: 16020894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synovial amyloidosis of beta 2-microglobulin type in patients undergoing long-term hemodialysis.
    Nakazawa R; Hamaguchi K; Hosaka E; Shishido H; Yokoyama T
    Nephron; 1986; 44(4):379-80. PubMed ID: 3540695
    [No Abstract]   [Full Text] [Related]  

  • 63. Fatal cardiac beta2-microglobulin amyloidosis in patients on long-term hemodialysis.
    Kawano M; Muramoto H; Yamada M; Minamoto M; Araki H; Koni I; Mabuchi H; Nonomura A
    Am J Kidney Dis; 1998 Mar; 31(3):E4. PubMed ID: 10074578
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intraosseous beta-2-microglobulin amyloidosis. Detection and measurement of osseous aluminum in a patient who was receiving long-term hemodialysis.
    Heller DS; Klein MJ; Gordon RE; Good P; Perl D
    J Bone Joint Surg Am; 1989 Aug; 71(7):1083-9. PubMed ID: 2668294
    [No Abstract]   [Full Text] [Related]  

  • 65. Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column.
    Ohashi K; Hara M; Kawai R; Ogura Y; Honda K; Nihei H; Mimura N
    Kidney Int; 1992 Jun; 41(6):1646-52. PubMed ID: 1501421
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Osteoarticular amyloidosis associated with haemodialysis: an immunoultrastructural study.
    Depierreux M; Goldman M; Fayt I; Richard C; Quintin J; Dhaene M; Van Herweghem JL
    J Clin Pathol; 1988 Feb; 41(2):158-62. PubMed ID: 3280607
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Beta2-Microglobulin dialysis amyloid and its formation: role of 3-deoxyglucosone and advanced glycation end products.
    Niwa T
    Nephron; 1997; 76(4):373-91. PubMed ID: 9274834
    [No Abstract]   [Full Text] [Related]  

  • 68. Beta-2-microglobulin amyloidosis in long-term dialysis patients.
    Stone WJ; Hakim RM
    Am J Nephrol; 1989; 9(3):177-83. PubMed ID: 2667360
    [No Abstract]   [Full Text] [Related]  

  • 69. The authors reply.
    Bataille S; Brunet P; Burtey S
    Kidney Int; 2014 Jan; 85(1):215. PubMed ID: 24380915
    [No Abstract]   [Full Text] [Related]  

  • 70. Mixed systemic amyloidosis in a patient receiving long term haemodialysis.
    Fernandez-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Hernanz-Mediano W
    J Clin Pathol; 1994 Jun; 47(6):560-1. PubMed ID: 8063944
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dialysis amyloidosis.
    Lancet; 1991 Aug; 338(8763):349-50. PubMed ID: 1677703
    [No Abstract]   [Full Text] [Related]  

  • 72. Bullous amyloidosis in a hemodialysis patient is myeloma-associated rather than hemodialysis-associated amyloidosis.
    Chang SL; Lai PC; Cheng CJ; Yang LC; Hong HS
    Amyloid; 2007 Jun; 14(2):153-6. PubMed ID: 17577689
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Complications suffered by dialysis patients. 5. Dialysis-induced amyloidosis].
    Gejo F; Takahashi N
    Nihon Naika Gakkai Zasshi; 2000 Jul; 89(7):1372-8. PubMed ID: 11032505
    [No Abstract]   [Full Text] [Related]  

  • 74. Beta 2-microglobulin levels in patients with renal insufficiency.
    Acchiardo S; Kraus AP; Jennings BR
    Am J Kidney Dis; 1989 Jan; 13(1):70-4. PubMed ID: 2643313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Amyloidosis in patients with end-stage renal failure: uraemia associated or dialysis related?
    Davison AM
    Contrib Nephrol; 1995; 113():92-100. PubMed ID: 7712726
    [No Abstract]   [Full Text] [Related]  

  • 76. Persistence of dialysis amyloid after renal transplantation. A case report.
    Sethi D; Brown EA; Cary NR; Woodrow DF; Gower PE
    Am J Nephrol; 1989; 9(2):173-4. PubMed ID: 2662775
    [No Abstract]   [Full Text] [Related]  

  • 77. Towards long-term dialysis: a personal view.
    Davison AM
    Artif Organs; 1999 Jan; 23(1):6-9. PubMed ID: 9950172
    [No Abstract]   [Full Text] [Related]  

  • 78. Beta 2-microglobulin amyloidosis in renal failure: understanding this recently recognized condition.
    Kay J
    Cleve Clin J Med; 1999 Mar; 66(3):145-7. PubMed ID: 10079583
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Long-term management of dialysis patients. II. Beta 2-microglobulin associated amyloidosis and acquired cystic kidney disease].
    Floege J; Segerer S; Schäffer J; Koch KM
    Internist (Berl); 1999 Jan; 40(1):64-9. PubMed ID: 10086302
    [No Abstract]   [Full Text] [Related]  

  • 80. Pseudotumoral amyloidosis of beta 2-microglobulin origin in the buttock of a patient receiving long term haemodialysis.
    Fernández-Alonso J; Rios-Camacho C; Valenzuela-Castaño A; Rocha-Castilla JL
    J Clin Pathol; 1993 Aug; 46(8):771-2. PubMed ID: 8408708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.